Full text not available from this repository.

Abstract

Background In 2019, the Australian life insurance industry introduced a partial moratorium (ban) limiting the use of genetic test results in life insurance underwriting. The moratorium is industry self-regulated and applies only to policies below certain financial limits (eg, $500 000 of death cover).Methods We surveyed Australian health professionals (HPs) who discuss genetic testing with patients, to assess knowledge of the moratorium; reported patient experiences since its commencement; and HP views regarding regulation of genetic discrimination (GD) in Australia.Results Between April and June 2020, 166 eligible HPs responded to the online survey. Of these, 86% were aware of the moratorium, but Conclusion While the current Australian moratorium is considered a step forward, most HPs believe it falls short of an adequate long-term regulatory solution to GD in life insurance.

Item Type:	Article
Authors/Creators:	Tiller, JM and Keogh, LA and McInerney-Leo, AM and Belcher, A and Barlow-Stewart, K and Boughtwood, T and Gleeson, P and Dowling, G and Prince, A and Bombard, Y and Joly, Y and Delatycki, M and Winship, IM and Otlowski, M and Lacaze, P
Keywords:	genetics, life insurance, moratorium, genetic discrimination
Journal or Publication Title:	Journal of Medical Genetics
Publisher:	BMJ Group
ISSN:	0022-2593
DOI / ID Number:	https://doi.org/10.1136/jmedgenet-2021-107989
Copyright Information:	© Author(s) (or their employer(s)) 2021
Related URLs:	Google Scholar: Otlowski, M UTAS Profile: Otlowski, M
Item Statistics:	View statistics for this item

Actions (login required)

Item Control Page